MedPAC Considers Zero Copay On Generic Drugs For Low-Income Part D Beneficiaries
This article was originally published in The Pink Sheet Daily
Executive Summary
At its Nov. 3 meeting, the Medicare Payment Advisory Commission agreed with a staff proposal to legislate lower copays as a way to encourage greater use of generics among those receiving the low-income subsidy in Medicare Part D.